Pierre A. Robe
Center for Biomedical Integrated Genoproteomics (CBIG) and Center for Cellular and Molecular Neurobiology (CNCM)
University of Liège
Belgium
Name/email consistency: high
- Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Robe, P.A., Nguyen-Khac, M.T., Lambert, F., Lechanteur, C., Jolois, O., Ernst-Gengoux, P., Rogister, B., Bours, V. Int. J. Oncol. (2007)
- A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. Robe, P.A., Martin, D., Albert, A., Deprez, M., Chariot, A., Bours, V. BMC. Cancer (2006)
- Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. Robe, P.A., Nguyen-Khac, M., Jolois, O., Rogister, B., Merville, M.P., Bours, V. BMC. Cancer (2005)
- Sodium bromide encephalopathy with decreased serum Cl- level and increased anion gap: report of one case. Robe, P.A., Sadzot, B., Frank, G. Eur. Neurol. (2004)
- Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. Robe, P.A., Jolois, O., N'Guyen, M., Princen, F., Malgrange, B., Merville, M.P., Bours, V. Int. J. Oncol. (2004)
- In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Robe, P.A., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.T., Jolois, O., Erkmen, K., Merville, M.P., Black, P.M., Bours, V. Clin. Cancer Res. (2004)
- Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside. Robe, P.A., Princen, F., Martin, D., Malgrange, B., Stevenaert, A., Moonen, G., Gielen, J., Merville, M., Bours, V. Biochem. Pharmacol. (2000)









